Posts

StromaForte by Swedish StromaBio for Ageing: Likelihood...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

StromaForte by Swedish StromaBio for Osteoarthritis: Li...

Nov 6, 2023

StromaForte is under clinical development by Swedish StromaBio and currently in ...

STAT turns 8: A letter from the executive editor

STAT turns 8: A letter from the executive editor

Nov 5, 2023

Today STAT turns 8! Read a letter from our executive editor @rickberke on the mi...

STAT+: Senate bill would permanently extend Covid-era rules on telehealth addiction treatment

STAT+: Senate bill would permanently extend Covid-era r...

Nov 5, 2023

A bipartisan bill would permanently extend a Covid-era policy that allowed patie...

STAT+: Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

STAT+: Novo Nordisk is concluding research on Wegovy’s ...

Nov 5, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

High biological age may increase the risk of dementia and stroke

High biological age may increase the risk of dementia a...

Nov 5, 2023

People who have a higher biological age than their actual chronological age have...

Medeor Therapeutics’ Innovative Kidney Transplant Cell Therapy Shows Promising Results

Medeor Therapeutics’ Innovative Kidney Transplant Cell ...

Nov 4, 2023

Medeor Therapeutics’ MDR-101 is a single-dose cell therapy designed to revolutio...

Kronos trims staff by 19% for phase 1/2 solid tumor drug

Kronos trims staff by 19% for phase 1/2 solid tumor drug

Nov 4, 2023

Kronos Bio, following promising outcomes in an initial evaluation of a phase 1/2...

AstraZeneca’s zibotentan granted new life in CKD trial

AstraZeneca’s zibotentan granted new life in CKD trial

Nov 4, 2023

In a surprising turn of events, AstraZeneca’s once-forgotten drug, zibotentan, h...

D3L-001 by D3 Bio for Human Epidermal Growth Factor Rec...

Nov 4, 2023

D3L-001 is under clinical development by D3 Bio and currently in Phase I for Hum...

D3L-001 by D3 Bio for Gastroesophageal (GE) Junction Ca...

Nov 4, 2023

D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gas...

RPA-601 by Rocket Pharmaceuticals for Cardiomyopathy: L...

Nov 4, 2023

RPA-601 is under clinical development by Rocket Pharmaceuticals and currently in...

Debio-4127 by Debiopharm International for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET): Likelihood of Approval

Debio-4127 by Debiopharm International for Neuroendocri...

Nov 4, 2023

Debio-4127 is under clinical development by Debiopharm International and current...

HUC-3443 by Huons for Idiopathic (Essential) Hypertensi...

Nov 4, 2023

HUC-3443 is under clinical development by Huons and currently in Phase II for Id...

HUC-3443 by Huons for Hypercholesterolemia: Likelihood ...

Nov 4, 2023

HUC-3443 is under clinical development by Huons and currently in Phase II for Hy...

QL-325 by QLSF Biotherapeutics for Acute Myelocytic Leu...

Nov 4, 2023

QL-325 is under clinical development by QLSF Biotherapeutics and currently in Ph...